Every year on 29 October, World Psoriasis Day raises awareness of the 125 million people worldwide living with psoriasis and psoriatic arthritis (PsA).
Chronic wounds present a huge social and economic burden; Consultant Podiatrist Debbie Sharman shares the importance of the Legs Matter coalition, which includes various healthcare charities dedicated to improving care for individuals with diabetic foot problems and other lower limb conditions.
An experimental drug known as ulefnersen has shown remarkable efficacy in treating a rare, aggressive form of ALS. Some patients experienced unprecedented functional recovery, offering new hope in a previously devastating diagnosis.
A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood.
A major clinical trial has found that low-dose interleukin-2 (IL2LD) is safe and may significantly extend survival in people with motor neurone disease (ALS).
A neuroscience mystery has been solved by using artificial intelligence (AI) to identify the electrical signatures of different types of brain neurons for the first time.
